Interestingly, a similar phenotype of TAMs and the expression of myeloid genes involved in antigen processing and presentation, chemoattraction or IFN signaling has been recently observed in baseline tumor biopsies of cancer patients responding to immune checkpoint inhibitors [62,63,64]. This evidence concerns the gene IFNA1 and neoplasm.